The purpose of this Notice is to correct the Eligibility information in PAR-18-947 "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01)".

Part 2. Full Text of Announcement, Section III. Eligibility Information, Eligible Applicants, Eligible Organizations

Currently reads:

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Corrected to read (in italics):

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

All other aspects of PAR 18-947 remain unchanged.

Inquiries

Please direct all inquiries to:

Lokesh Agrawal, Ph.D.
National Cancer Institute (NCI)
Telephone: (240) 276-5718
Email: [email protected]

Abhi Rao, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5715
Email:[email protected]